PortView
Wasatch Small/Mid Cap (WSMD) ETF Holdings & Analysis
ETFOther
Track WSMD in your portfolio for free · Portfolio tracker
What WSMD does
An actively managed exchange-traded fund (ETF) that seeks long-term capital appreciation by investing primarily in high-quality small- to mid-cap (SMID) companies. The fund focuses on a research-driven approach to identify companies with durable, long-term growth potential.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Halozyme Therapeutics Inc | 2.17% | |
| Manhattan Associates Inc | 2.02% | |
| Medpace Holdings Inc | 2.00% | |
| On Holding AG | 1.83% | |
| SharkNinja Inc | 1.77% | |
| Fabrinet | 1.73% | |
| RBC Bearings Inc | 1.73% | |
| West Pharmaceutical Services Inc | 1.69% | |
| UL Solutions Inc | 1.68% | |
| Saia Inc | 1.65% |
Geographic allocation
| United States | 91.55% |
| Switzerland | 1.84% |
| Cayman Islands | 1.73% |
| Israel | 2.17% |
| Ireland | 0.86% |
| Singapore | 0.74% |
| United Kingdom | 0.62% |
| Other | 0.50% |
PortView Portfolio Insights
PortView analyzes how WSMD fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze WSMD in PortView →Related securities
Related stocks
Frequently asked questions
- What does WSMD track?
- WSMD is the Wasatch Small/Mid Cap ETF, a Other ETF.
- What is the expense ratio of WSMD?
- Expense ratio data for WSMD is shown on the page when available from our data provider.
- What are the largest holdings in WSMD?
- Top holdings include HALO, MANH, MEDP, ONON, SN.
- How can PortView analyze WSMD overlap with other ETFs?
- PortView computes the holdings overlap between WSMD and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.